Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.960
-0.012 (-1.18%)
At close: Apr 28, 2026, 4:00 PM EDT
0.950
-0.010 (-1.04%)
Pre-market: Apr 29, 2026, 7:14 AM EDT
Bio Green Med Solution Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.75 | 0.04 | 0.42 | - | - | |
| Revenue Growth (YoY) | 1637.21% | -89.76% | - | - | - | |
| Cost of Revenue | 1.42 | 6.56 | 18.72 | - | - | |
| Gross Profit | -0.67 | -6.52 | -18.3 | - | - | |
| Selling, General & Admin | 7.72 | 5.39 | 6.72 | 7.38 | 7.46 | |
| Research & Development | 0.04 | 0.09 | 0.43 | 20.27 | 14.93 | |
| Operating Expenses | 7.75 | 5.49 | 7.15 | 27.66 | 22.39 | |
| Operating Income | -8.43 | -12 | -25.45 | -27.66 | -22.39 | |
| Interest & Investment Income | 0.06 | 0.01 | 0.27 | 0.21 | 0.02 | |
| Currency Exchange Gain (Loss) | 0.07 | -0.05 | -0.41 | 0.23 | 0.04 | |
| Other Non Operating Income (Expenses) | 0.35 | 0.05 | 0.05 | 1.3 | 0.14 | |
| EBT Excluding Unusual Items | -7.94 | -11.99 | -25.55 | -25.92 | -22.19 | |
| Gain (Loss) on Sale of Assets | 4.95 | - | - | - | - | |
| Pretax Income | -2.99 | -11.99 | -25.55 | -25.92 | -22.19 | |
| Income Tax Expense | 0.01 | -0.78 | -3 | -4.72 | -3.73 | |
| Net Income | -3 | -11.21 | -22.56 | -21.2 | -18.46 | |
| Preferred Dividends & Other Adjustments | 11.09 | - | 0.2 | 0.2 | 0.2 | |
| Net Income to Common | -14.09 | -11.21 | -22.76 | -21.4 | -18.66 | |
| Shares Outstanding (Basic) | 2 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 2 | 0 | - | - | - | |
| Shares Change (YoY) | 9692.40% | - | - | - | - | |
| EPS (Basic) | -6.45 | -502.46 | - | - | - | |
| EPS (Diluted) | -6.45 | -502.46 | - | - | - | |
| Free Cash Flow | -4.77 | -7.99 | -16.12 | -20.83 | -18.57 | |
| Free Cash Flow Per Share | -2.18 | -358.07 | - | - | - | |
| Gross Margin | -90.09% | - | - | - | - | |
| Operating Margin | -1128.11% | -27916.28% | -6060.24% | - | - | |
| Profit Margin | -1886.48% | -26074.42% | -5418.10% | - | - | |
| Free Cash Flow Margin | -638.55% | -18581.40% | -3837.62% | - | - | |
| EBITDA | -8.42 | -12 | -25.42 | -27.62 | -22.35 | |
| D&A For EBITDA | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 | |
| EBIT | -8.43 | -12 | -25.45 | -27.66 | -22.39 | |
| Revenue as Reported | 0.75 | 0.04 | 0.42 | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.